Envista’s latest quarter reflected stable demand in core dental markets but was overshadowed by ongoing macroeconomic uncertainty, particularly in the U.S. and China. Management noted that insurance-covered categories like prevention and diagnostics remained resilient, while elective areas such as ortho and implants lagged historical growth. CEO Paul Keel attributed the company’s margin expansion to continued factory and general administrative productivity, despite China’s sales contraction due to value-based procurement (VBP) preparations. “We converted good top-line performance into even stronger earnings growth,” Keel said, adding that strong free cash flow supported ongoing share repurchases this quarter.
Is now the time to buy NVST? Find out in our full research report (it’s free for active Edge members).
Envista (NVST) Q3 2026 highlights:
- Revenue $691.5 million vs S&P analysts’ estimates of $688.2 million (3.2% year-on-year growth, in line)
- Adjusted EPS $0.40 vs S&P analysts’ estimates of $0.36 (12.4% beat)
- Adjusted EBITDA $105.8 million vs analyst estimates of $97.38 million (15.3% margin, 8.6% beat)
- Adjusted EPS guidance Management raised its full-year adjusted EPS guidance to $1.56 at the midpoint, a 2.3% increase
- Operating margin 74.5%, up from 8.6% in the same quarter last year
- Market capitalization $4.00 billion
While we enjoy listening to the management’s commentary, our favorite part of earnings calls is the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.
Our top 5 analyst questions from Envista’s Q3 earnings call
- Brandon Vazquez (William Blair) asked about sustaining growth momentum into next year; CEO Paul Keel stressed the need to commercialize new product launches and maintain operational efficiency to offset macro headwinds.
- Vik Chopra (BMO Capital Markets) inquired about capital allocation priorities; Keel clarified organic investment and bolt-on M&A remain top priorities, with share repurchases limited to roughly one-third of free cash flow.
- Jeff Johnson (Baird) sought clarification on China VBP pricing impacts; Keel explained that inventory drawdowns in Q3 are distinct from the deeper price cuts expected to hit margins and revenues next year.
- John Block (Stifel) questioned the growth outlook for Spark clear aligners in Japan; Keel responded that Spark’s rapid Japan launch opens up a $200 million market, supporting sustained high single-digit growth.
- Lily Lozada (JPMorgan) asked about margin sustainability in the Equipment & Consumables segment; CFO Eric Hammes indicated that recent strong margins reflect product mix and productivity, and are generally sustainable barring major market shifts.
Catalysts in upcoming quarters
In the coming quarters, the StockStory team will monitor (1) the pace and breadth of new product adoption, especially for Spark and diagnostics, (2) the rollout and impact of China’s VBP reforms on both revenue and margins, and (3) stabilization or improvement in U.S. and European dental procedure volumes. Execution on commercialization and the ability to offset margin headwinds from China will be crucial to achieving guidance.
Envista currently trades at $25.17, down from $27.25 just before the earnings. At this price, is it a buy or sell? See for yourself in our full research report (it’s free).
The best stocks for high-quality investors
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.